Isis Patents definition

Isis Patents means the Patents originally owned by Isis and licensed by Isis to Sequenom under the Isis License, and that were sold, assigned and transferred to Sequenom before the Effective Date. The Isis Patents are set forth on Annex III.
Isis Patents means any and all patents, both foreign and domestic, which relate to inventions made by ISIS on or prior to the Effective Date which are necessary or useful to make, use or sell Collaboration Products including without limitation ISIS Target Patents. ISIS Patents will also include any patents relating to inventions made by ISIS after the Effective Date or licensed to ISIS before or after the Effective Date which are necessary or useful to make, use or sell Collaboration Products, provided that ISIS is free to license such patents to ZENECA and, provided further, that if ISIS developed or acquired such inventions for or from a Third Party, ISIS and ZENECA have mutually agreed on the terms upon which ISIS will provide such patents to ZENECA as provided in Paragraph 7.1(c). Notwithstanding the foregoing, ISIS Patents will include any Patents licensed to ISIS under the GMO License Agreement with no further payments required except as expressly provided in this Agreement. "Patents" as used herein will include, without limitation, all substitutions, extensions, reissues, renewals, divisions, continuations, continuations-in-part, inventors' certificates and all foreign counterparts of the aforementioned. Attached hereto as Exhibit G is a list of all ISIS' licenses as of the Effective Date that may be relevant to the Research Collaboration including the technology covered and the royalty rate.
Isis Patents means any and all patents, both foreign and domestic, which relate to inventions made by ISIS on or prior to the Effective Date which are necessary or useful to make, use or sell Collaboration Products including without limitation ISIS Target Patents. ISIS Patents will also include any patents relating to inventions made by ISIS after the Effective Date or licensed to ISIS before or after the Effective Date which are necessary or useful to make, use or sell Collaboration Products, provided that ISIS is free to license such patents to ZENECA and, provided further, that if ISIS developed or acquired such inventions for or from a Third Party, ISIS and ZENECA have mutually agreed on the terms upon which ISIS will provide such patents to ZENECA as provided in Paragraph 7.1(c). [ * ]. "Patents" as used herein will include, without limitation, all substitutions, extensions, reissues, renewals, divisions, continuations, continuations-in-part, inventors' certificates and all foreign counterparts of the aforementioned. Attached hereto as Exhibit G is a list of all ISIS' licenses as of the Effective Date that may be relevant to the Research Collaboration including the technology covered and the royalty rate.

Examples of Isis Patents in a sentence

  • In the event of any conflict between the language in this Section 2.1 and the provisions of any Ancillary Agreement granting a license under any Pooled Patent, or the licenses granted pursuant to Sections 2.2 (License to Sequenom Under Illumina Owned Patents) and 2.3 (Licenses to Illumina Under Sequenom Owned Patents and Isis Patents) of this Agreement, the applicable provisions in the Ancillary Agreement, Section 2.2, or Section 2.3 shall control.

  • Sequenom represents and warrants that the Isis Patents were sold, assigned and transferred to Sequenom, and the provisions of this Section 2.7 have been satisfied in full, before the Effective Date.

  • The effectiveness of this Agreement is subject to the due execution and delivery by Sequenom and Isis of a valid and binding agreement pursuant to which Sequenom purchases from Isis all right title and interest in and to the Isis Patents and receives full legal and beneficial title thereto, subject to the rights described in Schedule 7.1(b), and the satisfaction of any and all conditions precedent set forth therein.

  • The foregoing license grant in the NIPT LDT Field is subject to (i) any and all Existing Sequenom Licenses, and (ii) the reservation of the non-exclusive right, on behalf of Sequenom and its Affiliates, to Exploit NIPT LDT Tests in the NIPT LDT Field and to grant sublicenses under the Isis Patents to Persons that are not Sequencing Platform Manufacturers for each such sublicensee to Exploit NIPT LDT Tests in the NIPT LDT Field in its, or as applicable its Affiliates’, clinical laboratories.

  • Subject to the foregoing, solely with respect to infringement of the Isis Patents in the NIPT LDT Field, Sequenom, and in all other cases, Illumina, on behalf of itself and its respective Affiliates, will have the sole right to determine whether or not to take whatever legal or other action is required in response to activities described under Section 5.1(a), including such activities of which Sequenom becomes aware and provides notice under Section 5.1(a) (“Protective Action”).


More Definitions of Isis Patents

Isis Patents means Isis Patents (as such term is defined in the Isis Licence Agreement).
Isis Patents means Collaboration Patents that name Isis inventors and not CSHL inventors.
Isis Patents or "ATL Patents," respectively.
Isis Patents means any Patent Rights included in the Licensed Patents.
Isis Patents shall have the meaning as such term is defined in the Isis License Agreement.
Isis Patents means any and all patents and patent applications as set forth in Schedule 1, and all rights therein, and including all extensions, continuations, continuations-in-part, divisionals, patents-of-additions, re-examinations, re-issues, supplementary protection certificates and foreign counterparts thereto owned by or licensed to Isis containing claims relating to the Designated Oligonucleotide. Upon nomination and approval of an Additional Oligonucleotide, Schedule 1 shall be amended to include any and all patents and patent applications and all rights therein, and including all extensions, continuations, continuations-in-part, divisionals, patents-of-additions, re-examinations, re-issues, supplementary protection certificates and foreign counterparts thereto owned by or licensed to Isis containing claims relating to the Additional Oligonucleotide.